Stay updated on Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.

Latest updates to the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page
- Check4 days agoChange DetectedAncillary sponsor attribution and navigation link labels have been removed from the study record, reducing auxiliary information while preserving the primary study details.SummaryDifference0.1%

- Check11 days agoChange DetectedA new site revision is shown as Revision: v3.5.3, replacing the previous v3.5.2, indicating a software update underlying the page rendering.SummaryDifference0.0%

- Check18 days agoChange DetectedUpdated the page’s informational/footer elements (including the “More Information” area and helpful links) and refreshed the displayed site revision number from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check25 days agoChange DetectedThe sponsor line 'Naurex, Inc, an affiliate of Allergan plc' was removed. The sections 'More Information' and 'Helpful Links Provided by' were also removed.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.